Author:
Caloro Matteo,Calabrò Giuseppa,de Pisa Eleonora,Rosini Enrico,Kotzalidis Georgios D.,Lonati Davide,Locatelli Carlo Alessandro,Papa Pietro,Schifano Fabrizio,Girardi Paolo
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Reference16 articles.
1. Antitussives and substance abuse;Burns;Subst Abuse Rehabil,2013
2. Effects of ketamine and ketamine metabolites on evoked striatal dopamine release, dopamine receptors, and monoamine transporters;Can;J Pharmacol Exp Ther,2016
3. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance;Frison;Rapid Commun Mass Spectrom,2016
4. Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals;Hohmann;Dtsch Arztebl Int,2014
5. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors;Hustveit;Pharmacol Toxicol,1995
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献